Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06761963Not ApplicableNot Yet Recruiting

Chronic Effect of Whole-body Electrical Stimulation in COPD Patients

Role: collaborator

NCT04753151Not ApplicableUnknown

The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.

Role: collaborator

NCT04716426Not ApplicableCompleted

APT™ T3X on the COVID-19 Contamination Rate

Role: collaborator

NCT02376322Phase 2Completed

Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS

Role: lead

NCT00947323Phase 3Completed

Simvastatin for Treating Erectile Dysfunction

Role: lead

NCT01017081Not ApplicableCompleted

Chest Physiotherapy in Pediatrics Patients With Pneumonia

Role: lead

All 6 trials loaded